ABEV logo

ABEV Total Liabilities

Latest reportedR$49.32B BRL
ABEV Quarterly Total Liabilities · BRL (R$2.39B → R$49.32B)
High-resolution chart · PNG

ABEV total liabilities history

Quarterly · BRL. Dates are reporting period ends; fiscal years can differ from calendar years.

Ambev S.A. American Depositary Shares (Each representing 1 Common Share) Total Liabilities — Quarterly (BRL)
Period endingTotal Liabilities (BRL)
49,315,800,000
51,937,254,000
59,337,903,000
48,026,583,000
48,946,586,000
51,823,085,000
62,927,800,000
48,402,284,000
47,403,494,000
46,440,085,000
52,500,500,000
46,353,027,000
46,928,444,000
49,029,855,000
54,630,200,000
50,512,483,000
49,046,382,000
47,203,479,000
54,584,900,000
46,968,457,000
44,338,329,000
49,787,436,000
50,045,100,000
47,482,642,000
45,860,711,000
41,578,491,000
39,186,900,000
35,453,865,000
35,810,203,000
36,414,895,000
38,259,500,000
35,668,688,000
37,481,815,000
32,610,697,000
40,846,600,000
34,080,745,000
34,391,949,000
32,053,069,000
37,190,100,000
29,946,276,000
30,594,093,000
31,227,909,000
39,842,600,000
37,740,450,000
28,510,400,000
28,988,800,000
28,498,600,000
21,501,800,000
21,040,400,000
23,191,400,000
24,860,500,000
19,933,375,000
18,879,500,000
18,981,298,000
24,695,800,000
20,672,041,000
20,688,674,000
18,277,455,000
20,702,100,000
19,969,762,000
16,819,214,000
17,363,704,000
18,113,400,000
18,589,063,000
16,901,938,000
17,283,000,000
17,804,900,000
17,717,569,000
18,339,200,000
19,592,800,000
20,801,400,000
18,094,970,000
16,602,693,000
16,816,570,000
19,053,700,000
17,412,609,000
16,709,795,000
15,547,445,000
16,070,100,000
15,756,078,000
12,629,161,103
12,878,995,231
13,403,527,000
13,154,648,000
12,962,327,364
14,138,803,860
15,598,325,000
13,889,037,208
9,880,473,000
9,586,009,564
10,325,500,000
9,982,363,875
7,361,947,161
8,078,882,682
8,172,800,000
8,284,678,700
7,458,126,637
6,715,070,837
7,576,313,321
6,202,625,824
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.